Skip to navigation Skip to main content

Search...

Prostate Cancer
ED
CKD
Urology
- Urology
  Urology News
  
  Conference Coverage
  Benign Prostatic Hyperplasia (BPH)
  
  Bladder Cancer
  
  Erectile Dysfunction
  
  Hypogonadism
  
  Kidney Cancer
  Kidney Stones
  
  Men’s Health
  
  Overactive Bladder (OAB)
  
  Premature Ejaculation
  
  Prostate Cancer
  Reproductive Medicine
  
  Upper Tract Urothelial Carcinoma
  
  Urinary Incontinence
  
  Urinary Tract Infections (UTI)
Nephrology
- Nephrology
  Nephrology
  
  Conference Coverage
  Acute Kidney Injury
  
  Anemia
  
  Contrast Nephropathy
  
  Cardiovascular Disease (CVD)
  
  Chronic Kidney Disease (CKD)
  Diabetes
  
  Diabetic Nephropathy
  
  End-Stage Renal Disease
  
  Hemodialysis
  
  Hyperkalemia
  
  Hyperphosphatemia
  
  Hypertension
  Hyperuricemia
  
  Lupus Nephritis
  
  Nutrition
  
  Peritoneal Dialysis
  
  Secondary Hyperparathyroidism
  
  Transplantation
My Practice
- My Practice
  Commentary
  
  Drug Information Database
  
  Ethical Issues in Medicine
  
  General Medicine
  
  HIPAA Compliance
  
  Legal Issues in Medicine
  
  Practice Management
  
  Product Guide
Web Exclusives
- Web Exclusives
  Expert Perspectives
  
  Cartoons
  
  Clinical Quiz
  
  Drugs in the Pipeline
  Medical Calculators
  
  Medical Charts
  
  Multimedia
  
  Polls
  
  Prostate Cancer Management Across America
Conferences
Resources

Headlines
Jobs
Commentary
Poll
Drugs
CME

Submit

Manufacturers » P

Pfizer Ophthalmics

See Pfizer

Tel: (800) 438-1985

Drugs

XALATAN
- Glaucoma

Loading...
Loading...

Show More

Renal & Urology News publishes timely news coverage of scientific developments of interest to nephrologists and urologists, including in-depth coverage of all relevant medical conferences.

All of the news and departments from the print edition are fully archived on the site.

Resources

User Center

Other Haymarket Medical Websites

Copyright © 2021 Haymarket Media, Inc. All Rights Reserved
This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

Loading...

Loading...